Long-term left internal mammary artery graft patency for coronary artery disease associated with pseudoxanthoma

Howard K Song1, Erez Sharoni, Byron Williams

  • 1Section of Cardiothoracic Surgery and Division of Cardiology, Emory University, Atlanta, Georgia, USA.

Insights

Pseudoxanthoma elasticum (PXE) patients with coronary artery disease benefit from coronary artery bypass grafting (CABG). Long-term patency of left internal mammary artery (LIMA) grafts in PXE patients is demonstrated, supporting arterial conduit suitability.

Area of Science:

  • Cardiology
  • Genetics
  • Vascular Surgery

Background:

  • Pseudoxanthoma elasticum (PXE) is a rare inherited disorder affecting connective tissue.
  • PXE commonly leads to premature coronary artery disease (CAD).
  • Coronary artery bypass grafting (CABG) is a treatment for PXE-related CAD, but arterial conduit suitability is debated.

Observation:

  • A patient with PXE and CAD underwent off-pump CABG.
  • The procedure utilized left internal mammary artery (LIMA) and bilateral radial artery grafts.
  • Graft patency was assessed over the long term.

Findings:

  • The left internal mammary artery (LIMA) graft demonstrated long-term patency.
  • Bilateral radial artery grafts also remained patent.
  • This case supports the use of arterial conduits in PXE patients undergoing CABG.

Implications:

  • The findings suggest that arterial conduits, including LIMA, are suitable for CABG in PXE patients.
  • This may improve long-term outcomes for patients with this rare condition.
  • Further research into arterial graft use in PXE is warranted.

Related Concept Videos